ACE and COVID-19: Based on the protective role of ACE2 as a counter-regulator of Ang II/AT1-R effects, therapeutic approaches that restore the balance between ACE and ACE2 would be ideal to mitigate COVID-19–induced multiple organ injury in individuals without pre-existing medical conditions, preferably in combination with an effective antiviral agent.